Janumet XR 50 mg/500 mg
Janumet XR 50 mg/500 mg is a medicine authorised by Swissmedic under authorisation number 65052. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 July 2014 and the authorisation is valid without a time limit. ATC code A10BD07 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 65052 |
|---|---|
| Name | Janumet XR 50 mg/500 mg |
| Full name | Janumet XR 50 mg/500 mg, Filmtabletten |
| Authorisation holder | MSD Merck Sharp & Dohme AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BD07 |
| First authorisation | 30 July 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Janumet XR 50 mg/500 mg, Filmtabletten | B | 30 July 2014 |
| 2 | Janumet XR 50 mg/1000 mg, Filmtabletten | B | 30 July 2014 |
| 3 | Janumet XR 100 mg/1000 mg, Filmtabletten | B | 30 July 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 56 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 7 | 168 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 4 | 56 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 8 | 168 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 5 | 28 | Tablette(n) | A10BD07 | 07.06.2. | B |
| 9 | 84 | Tablette(n) | A10BD07 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Janumet XR 50 mg/500 mg authorised in Switzerland?
Yes. Janumet XR 50 mg/500 mg is authorised by Swissmedic under authorisation number 65052, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Janumet XR 50 mg/500 mg have?
Janumet XR 50 mg/500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Janumet XR 50 mg/500 mg?
The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.